OncClubAll Oncology News
InsightsMedNews WeekOncChatsOncLive News Network®OncLive TVPeer ExchangePodcastsRapid Readouts
Conference CoverageConference Listing
Giants of Cancer CareCME/CEScientific InterchangesState of the Science Summit / IPCNational Fellows ForumWebinars
PartnersPublications
Consensus ViewpointsOncLive AppInteractive ToolsSponsored
Biomarker ConsortiumSubscribe
Biosimilars
Brain Cancer
Breast CancerBreast Cancer
CAR T-cell Therapy
Disparities in Cancer Care
Gastrointestinal CancerGastrointestinal CancerGastrointestinal CancerGastrointestinal CancerGastrointestinal Cancer
Genitourinary CancersGenitourinary CancersGenitourinary Cancers
Global Oncology
Gynecologic OncologyGynecologic Oncology
Head & Neck Cancers
Hematologic OncologyHematologic OncologyHematologic OncologyHematologic OncologyHematologic OncologyHematologic Oncology
Immuno-Oncology
Lung Cancer
Melanoma & Skin Cancer
Oncology Business Management
Pediatric Oncology
Precision Medicine in Oncology®
Sarcomas
Supportive Care
Spotlight -
  • The OncLive Insider app is live!
  • CME Opportunities
Biosimilars
Brain Cancer
Breast CancerBreast Cancer
CAR T-cell Therapy
Disparities in Cancer Care
Gastrointestinal CancerGastrointestinal CancerGastrointestinal CancerGastrointestinal CancerGastrointestinal Cancer
Genitourinary CancersGenitourinary CancersGenitourinary Cancers
Global Oncology
Gynecologic OncologyGynecologic Oncology
Head & Neck Cancers
Hematologic OncologyHematologic OncologyHematologic OncologyHematologic OncologyHematologic OncologyHematologic Oncology
Immuno-Oncology
Lung Cancer
Melanoma & Skin Cancer
Oncology Business Management
Pediatric Oncology
Precision Medicine in Oncology®
Sarcomas
Supportive Care
    • Partners
    • Publications
    • Biomarker Consortium
    • Subscribe

Your AI-Trained Oncology Knowledge Connection!

scout
Advertisement

State of the Art: Treatment of Advanced Melanoma

home / peer-exchange / melanoma4-advanced-treatment
The Biology of  Advanced Melanoma

EP. 1: The Biology of Advanced Melanoma

July 14th 2016
Incorporating Prognostic Factors in Melanoma

EP. 2: Incorporating Prognostic Factors in Melanoma

July 14th 2016
Mutations of Clinical Significance in Melanoma

EP. 3: Mutations of Clinical Significance in Melanoma

July 14th 2016
Validity of PD-L1 Testing in Melanoma

EP. 4: Validity of PD-L1 Testing in Melanoma

July 14th 2016
Initial Strategies in Advanced Melanoma

EP. 5: Initial Strategies in Advanced Melanoma

July 14th 2016
Immunotherapy in Advanced Melanoma

EP. 6: Immunotherapy in Advanced Melanoma

July 14th 2016
Neoadjuvant Strategies in Melanoma

EP. 7: Neoadjuvant Strategies in Melanoma

July 14th 2016
Disease Burden and First-Line Melanoma Treatment

EP. 8: Disease Burden and First-Line Melanoma Treatment

July 14th 2016
Need for Subgroup Analyses in Melanoma Trials

EP. 9: Need for Subgroup Analyses in Melanoma Trials

July 14th 2016
Melanoma: BRAF/MEK Targeted Therapy

EP. 10: Melanoma: BRAF/MEK Targeted Therapy

July 14th 2016
Managing Brain Metastases and Side Effects in Melanoma

EP. 11: Managing Brain Metastases and Side Effects in Melanoma

July 14th 2016
Melanoma: Considerations in Checkpoint Inhibition

EP. 12: Melanoma: Considerations in Checkpoint Inhibition

July 14th 2016
Combination Strategies in Melanoma

EP. 13: Combination Strategies in Melanoma

July 14th 2016
Managing Lesions in Melanoma

EP. 14: Managing Lesions in Melanoma

July 14th 2016
Novel Approaches in Melanoma

EP. 15: Novel Approaches in Melanoma

July 14th 2016
Multi-Modality Treatment in Basal Cell Carcinoma

EP. 16: Multi-Modality Treatment in Basal Cell Carcinoma

July 14th 2016

Latest Conference Coverage

First-Line Rucaparib Maintenance Reduces Progression Risk Across Prognostic Subgroups in HRD– High-Grade Ovarian Cancer

Raludotatug Deruxtecan Shows Activity in Platinum-Sensitive Ovarian Cancer

Relacorilant/Nab-Paclitaxel Is Associated With Survival Improvement in Platinum-Resistant Ovarian Cancer After Short Platinum-Free Interval

PD-L1 CPS Does Not Enrich the Efficacy of Atezolizumab/Bevacizumab and Chemo in Advanced Cervical Cancer

View More Latest Conference Coverage
Advertise
About OncLive
Editorial Board
MJH Life Sciences brands
Contact Us
Privacy
Terms & Conditions
Do Not Sell My Information
Contact Info

2 Commerce Drive
Cranbury, NJ 08512

609-716-7777

Download on Apple
© 2025 MJH Life Sciences

All rights reserved.
Home
About Us
News
Contact